Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Labeling errors & mix-ups

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose.

1,411 FDA drug recalls with this cause, newest first.

This is exactly what it sounds like: the wrong label on the right product, the wrong strength printed on the bottle, a missing or illegible lot number and expiry date, or two products mixed up during packaging. It is dangerous precisely because the pill or liquid itself may be fine, yet the patient has no way of knowing what they are actually taking. A high share of the Class I recalls in this group are mix-ups where a stronger product ended up in a weaker product's packaging.

Class II · Moderate risk

Articaine DENTAL

Labeling: Not Elsewhere Classified. This recall has been initiated due to mislabeling. The printed carton used in manufacturing both batches contained text for both 2% Xylocaine DENTAL and Articadent DENTAL. Xylocaine DENTAL is a trade name for Lidocaine HCL 2% and Epinephrine 1: 100,000 formulation, while Articadent DENTAL is a trade name for Articaine HCI 4% and Epinephrine 1 :100,000. The cartridges contained within the printed carton are labeled appropriately as Articadent DENTAL.

Terminated Labeling / mix-up Septodont Inc. NDC 66312-601-16 D-1307-2019
Class III · Low risk

Relpax (eletriptan HBr)

Labeling: Label Error on Declared Strength: an artwork error on the secondary packaging of Relpax 40 mg Tablets, indicates that each tablet contains eletriptan hydrobromide equivalent to 20mg eletriptan, instead of 40mg, on one side of the carton.

Terminated Labeling / mix-up Pfizer Inc. NDC 0049-2340-05 D-1278-2019
Class III · Low risk

Dermoplast Anesthetic PAIN & ITCH

Labeling: Not Elsewhere Classified: Full cases may contain canisters that incorrectly state the net weight is 2.75 oz. rather than the correct net weight of 2.0 oz.

Terminated Labeling / mix-up Advantice Health D-1280-2019
Class III · Low risk

Dermoplast Anesthetic PAIN & ITCH

Labeling: Not Elsewhere Classified: canisters incorrectly state the net weight is 2.75 oz. rather than the correct net weight of 2.0 oz.

Terminated Labeling / mix-up Advantice Health D-1279-2019
Class II · Moderate risk

Carvedilol Tablets

Labeling; Label Mix-up; report received of one bottle labeled as Acyclovir Tablets USP 400 mg actually contained Carvedilol Tablets 6.25 mg

Terminated Labeling / mix-up Zydus Pharmaceuticals USA Inc NDC 68382-093-05 D-1273-2019
Class II · Moderate risk

Acyclovir Tablets

Labeling; Label Mix-up; report received of one bottle labeled as Acyclovir Tablets USP 400 mg actually contained Carvedilol Tablets 6.25 mg

Terminated Labeling / mix-up Zydus Pharmaceuticals USA Inc NDC 68382-791-01 D-1272-2019
Class I · High risk

FENTANYL Transdermal System

Product Mix-Up: Customer complaint that their carton labeled as Fentanyl Transdermal Systems, 12 mcg/h contained five patches labeled and containing 50 mcg/h.

Terminated Labeling / mix-up Alvogen, Inc NDC 47781-423-47 D-1277-2019
Class III · Low risk

Clonidine HCL Injection

Labeling: Label Error on Declared Strength: Side carton panel incorrectly lists the concentration as "500 mcg Clonidine Hydrochloride" rather than the correct concentration of "100 mcg Clonidine Hydrochloride" per mL.

Terminated Labeling / mix-up X-Gen Pharmaceuticals Inc. NDC 39822-2000-1 D-1084-2019
Class II · Moderate risk

Phenobarbital Oral Solution

Labeling: Incorrect or Missing Lot and/or Exp Date - the label contains an incorrect Exp Date.

Terminated Labeling / mix-up Lohxa LLC NDC 70166-536-02 D-1131-2019
Class II · Moderate risk

Gavilyte-N

Labeling Not Elsewhere Classified; orange and cherry flavor packets incorrect list "natural lemon flavor" as an ingredient

Terminated Labeling / mix-up Lupin Somerset NDC 43386-050-19 D-1113-2019
Class II · Moderate risk

MAGnesium 2 gm sulfate

Labeling: Incorrect or Missing Lot and/or Exp Date:The product labels contain a Two-Dimensional ( 2D ) barcode that, when scanned, reveals information specific to the batch of the labeled product, including Expiration Date. The expiration date included within these 2D barcodes is incorrect and does not match the correct expiration date listed on the face of the label itself.

Terminated Labeling / mix-up Avella of Deer Valley, Inc. Store 38 NDC 42852-907-05 D-1000-2019
Class II · Moderate risk

MAGnesium 2gm sulfate

Labeling: Incorrect or Missing Lot and/or Exp Date:The product labels contain a Two-Dimensional ( 2D ) barcode that, when scanned, reveals information specific to the batch of the labeled product, including Expiration Date. The expiration date included within these 2D barcodes is incorrect and does not match the correct expiration date listed on the face of the label itself.

Terminated Labeling / mix-up Avella of Deer Valley, Inc. Store 38 NDC 42852-902-05 D-0999-2019
Class II · Moderate risk

MAGnesium 1gm sulfate

Labeling: Incorrect or Missing Lot and/or Exp Date:The product labels contain a Two-Dimensional ( 2D ) barcode that, when scanned, reveals information specific to the batch of the labeled product, including Expiration Date. The expiration date included within these 2D barcodes is incorrect and does not match the correct expiration date listed on the face of the label itself.

Terminated Labeling / mix-up Avella of Deer Valley, Inc. Store 38 NDC 42852-901-05 D-0998-2019
Class II · Moderate risk

Labetalol 20mg

Labeling: Incorrect or Missing Lot and/or Exp Date:The product labels contain a Two-Dimensional ( 2D ) barcode that, when scanned, reveals information specific to the batch of the labeled product, including Expiration Date. The expiration date included within these 2D barcodes is incorrect and does not match the correct expiration date listed on the face of the label itself.

Terminated Labeling / mix-up Avella of Deer Valley, Inc. Store 38 NDC 42852-822-71 D-0997-2019
Class III · Low risk

Mometasone Furoate Cream

Labeling: Not Elsewhere Classified. Mometasone Furoate Cream has an NDC typographical error.

Terminated Labeling / mix-up ACP Nimble Buyer, Inc. NDC 0713-0726-37 D-0514-2019
Class II · Moderate risk

LET Gel 4%

Labeling: Incorrect or Missing Lot and/or Exp Date: Labels are missing lot and expiration date and are printed as Lot# YYYDDYY@XX with a Beyond Use Date: MM/DD/YYY.

Terminated Labeling / mix-up US Compounding Inc D-0482-2019
Class II · Moderate risk

Docusate Sodium

Labeling: Label mix-up: Secondary carton may be labeled as Gabapentin 300mg instead of Docusate Sodium 100mg softgel caps.

Terminated Labeling / mix-up Rx Pak Division of McKesson Corporation NDC 63739-0478-10 D-1007-2019
Class II · Moderate risk

HEPERAIN 50 mg/50 mL

Labeling; Label Error on Declared Strength; label incorrectly states the concentration as 50 mg/50 mL (1 mg/mL) rather than the fully accurate concentration as 50 Units/50 mL (1 Unit/mL)

Terminated Labeling / mix-up Advanced Pharma Inc. D-0430-2019
Class III · Low risk

Loperamide HCL Tablets USP

Labeling Not Elsewhere Classified: The front panel indicates 24 caplets whereas the side panel indicates 12 caplets. The drug product carton contains 24 caplets.

Terminated Labeling / mix-up Sun Pharmaceutical Industries, Inc. D-0391-2019
Class I · High risk

Dyural-80 Injection Kit

Labeling: Not eslewhere classified - The kits include Sodium Chloride, USP, 0.9% which was recalled by the manufacturer due to the product insert incorrectly stating stoppers do not contain latex. The stoppers contain natural rubber latex

Terminated Labeling / mix-up Asclemed USA Inc. dba Enovachem NDC 76420-0755-01 D-0354-2019